Infection Control Find the newest stories covering infection and disease control in hospitals, care homes, and the general population. This section contains information on testing, monitoring, treatment options, vaccine development and distribution, as well as new policy decisions and best practices. Also included are announcements of educational and awareness campaigns. Follow new advances in infection control and prevention with releases about new study results and updated statistical data and analysis.

Latest

07:00 ET Biomica to Collaborate With Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic Resistant Bacteria

Biomica, an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN)...


Oct 22, 2019, 09:30 ET The Michael J. Fox Foundation's Edmond J. Safra Fellowship in Movement Disorders Selects Class of 2022

The Edmond J. Safra Fellowship in Movement Disorders has selected five neurology physicians for the Class of 2022, the program's fifth class, from...


Oct 22, 2019, 08:00 ET Gastro Girl, Inc. and American College of Gastroenterology Introduce GI OnDEMAND: Gastroenterology's Virtual Care and Support Platform

EMBARGOED FOR RELEASE October 28, 2019 at 8 am CDT - Gastro Girl, Inc., in partnership with the American College of Gastroenterology, today announces ...


Oct 21, 2019, 10:00 ET When Prions are Personal

A research team with an especially personal stake in prion diseases reports in the journal Molecular & Cellular Proteomics a new measurement that may ...


Oct 17, 2019, 17:30 ET Pritzker Hageman Legionnaires' Disease Law Firm Files First Lawsuit in North Carolina Mountain State Fair Hot Tub Legionnaires' Outbreak

National Legionnaires' disease law firm, Pritzker Hageman, P.A., along with local counsel Ralph W. Meekins, today filed the first Legionnaires'...


Oct 17, 2019, 09:00 ET Mirati Therapeutics To Present Pre-Clinical And Initial Clinical Data For MRTX849, A KRAS G12C Inhibitor, At The 2019 AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced it will present pre-clinical data and initial...


Oct 17, 2019, 08:00 ET Accelerate Diagnostics Schedules Call to Review Third Quarter 2019 Results

Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the third quarter of 2019 after the market...


Oct 16, 2019, 08:00 ET Apexigen's CEO, Xiaodong Yang, Recognized Among 100 Most Intriguing Entrepreneurs at Goldman Sachs 2019 Builders + Innovators Summit

Apexigen, Inc. announced today that Goldman Sachs is recognizing its founder and CEO, Xiaodong Yang, as one of the 100 Most Intriguing Entrepreneurs...


Oct 16, 2019, 08:00 ET Pathologist Creates Powerful Program Providing Patients an Up-Close and Personal Look at Their Cancer

Carol Palmer thought she beat the odds, after being diagnosed with invasive breast cancer at age 45. She successfully underwent treatment and was...


Oct 15, 2019, 14:37 ET Campaign Focuses on Stopping HIV Stigma Among the Latinx Community

Pinyon Foundation has partnered with The Centers for Disease Control and Prevention (CDC) in the launch of a new Spanish-language campaign focused on ...


Oct 15, 2019, 11:02 ET New Hand Hygiene Campaign Promotes Community Health to Reduce Illness and Infection

According to the Centers for Disease Control and Prevention (CDC), handwashing can prevent one in three cases of diarrhea and one in five respiratory ...


Oct 14, 2019, 10:30 ET CareOne is RID Recognized to Ensure Patient Health and Safety

CareOne, New Jersey's largest family owned and operated senior care company is proud to announce they have been named the first post-acute care and...


Oct 11, 2019, 05:30 ET Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies...


Oct 11, 2019, 02:00 ET Shionogi enters into a new license agreement and research collaboration for the treatment of mycobacterial diseases with Hsiri Therapeutics, Inc.

Shionogi & Co., Ltd. (Head Office: Osaka; President and CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announced that it has entered into a...


Oct 10, 2019, 16:05 ET Armata Pharmaceuticals Expands Board of Directors with the Appointment of Research and Development Veteran Todd C. Peterson, Ph.D.

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage...


Oct 10, 2019, 13:57 ET FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens

Today, the U.S. Food and Drug Administration allowed marketing of a rapid diagnostic test (RDT) to detect Ebola virus antigens (proteins) in human...


Oct 10, 2019, 12:43 ET The Washington Poison Center receives national recognition for media and public health engagement

The Washington Poison Center was recently recognized by the American Association of Poison Control Centers (AAPCC) for its efforts in media and...


Oct 08, 2019, 17:01 ET ABL, Inc. consigue un contrato IDIQ para servicios de fabricación cGMP en apoyo al programa PREVENT

Advanced BioScience Laboratories, Inc. (ABL), una organización global de desarrollo y fabricación por contrato de productos bioterapéuticos y...


Oct 08, 2019, 12:30 ET Fifth-straight year of STD increases demands urgent action

CDC data released today show that STDs in the US hit all-time highs in 2018, after five straight years of dramatic increases. These steep increases...


Oct 08, 2019, 10:53 ET ABL, Inc. obtient un marché IDIQ à fournisseurs multiples visant l'offre de services de fabrication cGMP dans le cadre du programme de prévention du cancer préclinique PREVENT Cancer

Aujourd'hui, Advanced BioScience Laboratories, Inc. (ABL), une entreprise mondiale de développement et de fabrication en sous-traitance de produits...


Oct 08, 2019, 10:51 ET ABL, Inc., erhält mehrteiligen IDIQ-Auftrag über cGMP-Produktionsleistungen im Rahmen des präklinischen Krebspräventionsprogramms PREVENT

Advanced BioScience Laboratories, Inc. (ABL), ein globales Auftragsentwicklungs- und Produktionsunternehmen für Biotherapeutika und Impfstoffe, hat...


Oct 08, 2019, 09:00 ET Vast Therapeutics Receives Qualified Infectious Disease Product Status for BIOC11

Vast Therapeutics, Inc., a subsidiary of KNOW Bio, LLC, today announced that another of its drug candidates, BIOC11, has been designated as a...


Oct 08, 2019, 08:52 ET New York State Grants Approval for IGeneX's Newly Developed Tick-Borne Relapsing Fever (TBRF) ImmunoBlot Tests

The Division of Laboratories of the Department of Health of the State of New York has approved IGeneX's newly developed Tick-Borne Relapsing Fever...


Oct 08, 2019, 08:00 ET Sekisui Diagnostics Announces FDA Clearance and CLIA Waiver of the Acucy™ Influenza A&B Test

Sekisui Diagnostics announces the Acucy Influenza A&B Test has received 510(k) clearance as a Class II assay from the US Food and Drug Administration ...


Oct 08, 2019, 08:00 ET ABL, Inc. Awarded Multiple-Award IDIQ Contract to Provide cGMP Manufacturing Services in support of the PREVENT Cancer Preclinical Cancer Prevention Program

Advanced BioScience Laboratories, Inc. (ABL), a global contract development and manufacturing organization for biotherapeutics and vaccines,...